30720-25-3

Basic information

• Product Name: 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER;ETHYL-4-CHLORO-1-ETHYL-1H-PYRAZOLE [3,4]PYRIDINE-5-CARBOXYLATE;1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid, 4-chloro-1-ethyl-, ethyl ester;Ethyl 4-chloro-1-ethyl-pyrazolo[3,4-b]pyridine-5-carboxylate
• CAS NO: 30720-25-3
• Molecular Formula: C₁₁H₁₂ClN₃O₂
• Molecular Weight: 253.68
• Mol File: 30720-25-3.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 348.51°C at 760 mmHg
• Flash Point: 164.573°C
• Appearance: /
• Density: 1.377g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.619
• PKA: 1.43±0.30(Predicted)
• CAS DataBase Reference: 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER(30720-25-3)
• EPA Substance Registry System: 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER(30720-25-3)

Safety Data

• Hazardous Substances Data: 30720-25-3(Hazardous Substances Data)

Usage

General Description

4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER is a chemical compound with the molecular formula C12H13ClN4O2. It is an ethyl ester derivative of pyrazolo[3,4-b]pyridine-5-carboxylic acid, containing a chlorine atom and an ethyl group. 4-CHLORO-1-ETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID ETHYL ESTER is a pyrazolopyridine derivative, which is a class of heterocyclic compounds with potential pharmacological activities. Its specific uses and applications may vary depending on its properties and potential interactions with other substances, and it may be used in pharmaceutical research and development, chemical synthesis, or other industrial applications. As with any chemical compound, proper handling and disposal procedures should be followed to ensure safety and compliance with regulations.

InChI:InChI=1/C11H12ClN3O2/c1-3-15-10-7(6-14-15)9(12)8(5-13-10)11(16)17-4-2/h5-6H,3-4H2,1-2H3

Upstream product

• 3528-58-3 5-Amino-1-ethylpyrazole 
• 87-13-8 diethyl 2-ethoxymethylenemalonate 
• 26823-99-4 [[(1-ethyl-5-pyrazolyl)amino]methylene]malonic acid diethyl ester 
• 30720-04-8 1-ethyl-4-hydroxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl ester 

Downstream Products

• 261771-29-3 4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid 
• 34966-24-0 1-ethyl-4-isobutylamino-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl ester 
• 1049619-86-4 C₁₈H₂₀N₄O₃ 
• 34966-41-1 4-(butylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl ester 
• 34966-42-2 4-anilino-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl ester 
• 1049619-87-5 C₁₈H₁₉FN₄O₂ 
• 1340592-14-4 1-ethyl-4-(4-fluoro-2-methylphenyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid 
• 1340592-15-5 [1-ethyl-4-(4-fluoro-2-methyl-phenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl]-methyl-amine 
• 1340591-74-3 2-(3,5-bis-trifluoromethyl-phenyl)-N-[1-ethyl-4-(4-fluoro-2-methyl-phenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-isobutyramide 
• 1340591-73-2 2-(3,5-bis-trifluoromethyl-phenyl)-N-(1-ethyl-4-o-tolyl-1H-pyrazolo[3,4-b]pyridin-5-yl)-N-methyl-isobutyramide 
• 865718-72-5 GSK₃₂₅₉₇₁A 
• 1224047-81-7 C₁₆H₁₄Cl₂N₄O 
• 1224047-83-9 C₁₇H₁₇ClN₄O 
• 1224047-76-0 C₁₇H₁₃Cl₂F₃N₄O 

Relevant articles and documents

Dual functional cholinesterase and PDE4D inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of tacrine-pyrazolo[3,4-b]pyridine hybrids

A series of tacrine-pyrazolo[3,4-b]pyridine hybrids were synthesised and evaluated as dual cholinesterase (ChE) and phosphodiesterase 4D (PDE4D) inhibitors for the treatment of Alzheimer's disease (AD). Compound 10j, which is tacrine linked with pyrazolo[

PYRRAZOLOPYRIDINE COMPOUNDS AS DUAL NK1/NK3 RECEPTOR ANTAGONISTS

The present invention relates to a compound of formula I wherein R1, R2, R3, Ar, and n are as defined herein or to a pharmaceutically active acid addition salt. Compounds of formula I show a high affinity simultaneously to

SUBSTITUTED PYRAZOLO [3,4-B]PYRIDINES AS PHOSPHODIESTERASE INHIBITORS

The present invention relates to phosphodiesterase (PDE) type IV selective inhibitors. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type IV selective inhibitors are provided. Prepared compounds correspond to structure XIV.